Digipath
CHM Cannabis
Home > Boards > US Listed > Medical - Drugs >

Spectrum Pharmaceutecals, Inc. (SPPI)

SPPI RSS Feed
Add SPPI Price Alert      Hide Sticky   Hide Intro
Moderator: antihama
Search This Board: 
Last Post: 12/13/2018 12:18:06 PM - Followers: 81 - Board type: Free - Posts Today: 0

http://www.spectrumpharm.com/

- Spectrum Pharmaceuticals Highlights Poziotinib Data in Non-Small-Cell Lung Cancer (NSCLC) Presented at the 18th IASLC World Conference on Lung Cancer in Japan  - PR

http://investor.sppirx.com/releasedetail.cfm?ReleaseID=1044288
 

- 18th IASLC World Conference on Lung Cancer: Poziotinib Update - Conference Call 

https://edge.media-server.com/m6/p/4r5me9dd

.  

 

Digipath
CHM Cannabis
SPPI
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
SPPI News: Statement of Changes in Beneficial Ownership (4) 12/07/2018 05:34:14 PM
SPPI News: Spectrum Pharmaceuticals Announces Results from the RECOVER Phase 3 Study of ROLONTIS® (eflapegrastim) at the 2018 SABCS Ann... 12/06/2018 07:00:00 AM
SPPI News: Spectrum Pharmaceuticals Announces Positive Results from Phase 2 Trial Evaluating Use of Oral Leucovorin to Potentially Mitig... 12/03/2018 07:00:00 AM
SPPI News: Spectrum Pharmaceuticals Highlights Three Posters at the 60th Annual Meeting of the American Society of Hematology 11/30/2018 07:00:00 AM
SPPI News: Current Report Filing (8-k) 11/13/2018 07:02:51 AM
PlusOneCoin Top Posts
No plusone'd posts yet. Be the first!
PostSubject
#2395   Went over to the Yahoo board to see antihama 12/13/18 12:18:06 PM
#2394   Interesting how this downdraft in tech affects Spectrum Pharma. antihama 12/08/18 08:06:16 AM
#2393   err Wrapping :) Doji Dragonfly 12/07/18 05:06:45 AM
#2392   They are taking there sweet time warping our Doji Dragonfly 12/07/18 05:05:42 AM
#2391   Are they looking to hire more Clinical/Regulatory? antihama 12/06/18 12:06:55 PM
#2390   Ya know, from today's Rolontis RECOVER P3 PR, antihama 12/06/18 11:03:53 AM
#2389   Amgen’s receives FT based on 10 patients. antihama 12/04/18 06:06:38 PM
#2388   CASI Pharmaceuticals' EVOMELA approved in China! antihama 12/03/18 02:00:00 PM
#2387   Leucovorin Mitigates Mucositis in Patients Treated with FOLOTYN. antihama 12/03/18 07:35:41 AM
#2385   Sometimes, the words not spoken are the loudest. antihama 11/23/18 08:08:21 AM
#2384   CASI: H.C. Wainwright is maintaining its Buy rating antihama 11/21/18 10:55:24 AM
#2383   New Presentation; same as the Jefferies 2018 London antihama 11/20/18 04:47:27 PM
#2382   No problemo! antihama 11/20/18 04:44:18 PM
#2381   Pozi competition prognosis? Pozi is in good shape antihama 11/20/18 04:43:07 PM
#2380   Sorry antihama, he went on my least favorite Doji Dragonfly 11/20/18 02:03:12 PM
#2379   Hi Doji, can you do me a favor antihama 11/19/18 11:26:45 PM
#2378   Thanks for your input Vavavoom 11/18/18 09:18:14 AM
#2377   DS-8201a is not a competitor to Pozi exon20 antihama 11/18/18 07:22:36 AM
#2376   I mean how did they identify the her2 Vavavoom 11/17/18 03:40:43 PM
#2375   Antihama, Any thoughts on ds-8201 Vavavoom 11/17/18 09:35:19 AM
#2374   Comments on Jefferies London HCC CC 11.14.19 antihama 11/15/18 01:15:36 PM
#2373   I don't think PFS will weigh-in on BTD antihama 11/13/18 01:54:28 PM
#2372   Ville is at 80% Ville 11/13/18 11:41:27 AM
#2371   A little doubt remains: Ville 11/13/18 11:39:48 AM
#2370   A Rolontis 'Guy', Dr. Vacirca joins the BOD. antihama 11/13/18 07:58:39 AM
#2369   make it 99% but not 100% antihama 11/12/18 04:16:15 PM
#2368   antihama....make it 99% but not 100% :) Doji Dragonfly 11/12/18 03:54:50 PM
#2367   Hi muchogusto, antihama 11/12/18 02:39:13 PM
#2366   Thank you antihama, for your insightful analysis. muchogusto 11/11/18 03:42:07 AM
#2365   3rd Q CC impressions. antihama 11/09/18 08:41:28 AM
#2364   Continuing evidence discrediting Sept's short article pozi pricing. antihama 11/07/18 08:30:19 AM
#2363   Janssen collaboration for NSCLC EGFR-TKI Valued up-to $1.25B antihama 11/06/18 01:22:22 PM
#2362   One small step for Evomela, one big step antihama 11/06/18 08:14:32 AM
#2361   PDX(Folotyn) has demonstrated compelling activity in combination with antihama 11/05/18 04:57:59 PM
#2360   Use of Leucovorin As Adjunct to Pralatrexate @ASH2018. antihama 11/05/18 04:49:13 PM
#2359   A long-time long's lament (or jealous of SGEN). antihama 11/05/18 11:09:23 AM
#2358   I’m saddened to think what this patient went antihama 11/05/18 07:56:06 AM
#2357   Metastatic Breast Cancer Patient With Activating HER2 Exon AVII77 11/05/18 06:49:44 AM
#2356   Combination with Kadcyla will be telling. I hope Ville 11/05/18 05:56:24 AM
#2355   Frankly i don't know. But it is not Ville 11/05/18 05:54:24 AM
#2354   Poziotinib showed the most potent activity against HER2 antihama 11/04/18 12:17:37 PM
#2353   Reason #3 to why trial sites were removed. antihama 11/03/18 10:11:54 AM
#2352   Pozi P2 HER2 positive metastatic breast cancer study. antihama 11/02/18 10:40:21 PM
#2351   Oh Rolontis BLA where art thou? antihama 11/01/18 02:38:21 PM
#2350   Hi Ville, kojak007 11/01/18 12:52:32 PM
#2349   Pozi's future pan EGFR 'to do' list. antihama 10/31/18 10:49:04 AM
#2348   SPPI Pozi trial interim analysis early data readout. antihama 10/30/18 10:19:15 AM
#2347   So does Pozi fit the following criteria (rhetorical?) antihama 10/29/18 05:18:52 PM
#2346   That is an excellent overview antihama Thanks Doji Dragonfly 10/29/18 03:11:04 PM
#2345   FDA Expedited Programs Overview with Focus on BTD. antihama 10/29/18 01:54:02 PM
PostSubject